Michael Heaney

Michael Heaney serves as a key procurement lead within the National Cancer Institute (NCI), supporting the agency’s mission to accelerate cancer research through strategic acquisition of advanced scientific and diagnostic technologies. He manages a portfolio of contracts focused on high-complexity research infrastructure, genomic analysis platforms, and translational diagnostic tools, ensuring alignment with NCI’s priorities in precision medicine and laboratory innovation. His work directly enables the deployment of cutting-edge technologies across NIH-funded research centers, emphasizing compliance with federal acquisition regulations and scientific rigor in vendor selection. Heaney maintains a strong, ongoing partnership with Roche Diagnostics Corporation, a leading provider of molecular diagnostics and oncology research solutions. His contracting patterns reflect a preference for established industry leaders with proven capabilities in clinical-grade assay development, next-generation sequencing systems, and bioinformatics integration. These relationships are characterized by long-term, performance-based contract structures designed to support sustained research output and technological scalability. Heaney demonstrates an unwavering commitment to small business participation, with 100% of his acquisitions structured as total small business set-asides under FAR 19.5. This reflects a deliberate strategy to cultivate innovation from emerging life sciences startups and specialized research service providers, ensuring diverse technical perspectives and agile solutions within the NCI’s research ecosystem. His contracting approach consistently prioritizes socioeconomic programs that expand access for small disadvantaged businesses and other eligible small entities. While specific NAICS codes are not available, his procurement activity centers on laboratory instrumentation, molecular diagnostics, bioanalytical services, and research support systems—domains critical to cancer genomics and translational science. Heaney’s expertise lies in acquiring technically sophisticated, regulatory-compliant tools that enable high-throughput data generation and clinical validation, directly supporting NCI’s scientific advancement goals.